# ESTRELLA IMMUNOPHARMA INC (ESLAW)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ESLAW/

- Reporting holders: 8
- Reported value: $245.1K
- Shares held by institutions: 433,694 of 43,497,864 outstanding
- Held through calls: 1.6%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [BOOTHBAY FUND MANAGEMENT, LLC](https://holderbook.com/funds/1549230-boothbay-fund-management-llc/) | $197.5K | 189,899 | 0.0% | 11 |
| [Robertson Stephens Wealth Management, LLC](https://holderbook.com/funds/1767307-robertson-stephens-wealth-management-llc/) | $12.5K | 12,000 | 0.0% | 3 |
| [D. E. Shaw & Co., Inc.](https://holderbook.com/funds/1009207-d-e-shaw-co-inc/) | $12.5K | 87,500 | 0.0% | 11 |
| [Yakira Capital Management, Inc.](https://holderbook.com/funds/1584639-yakira-capital-management-inc/) | $6.0K | 46,285 | 0.0% | 11 |
| [WHITEBOX ADVISORS LLC](https://holderbook.com/funds/1257391-whitebox-advisors-llc/) | $5.5K | 42,293 | 0.0% | 11 |
| [Clear Street Group Inc.](https://holderbook.com/funds/1881567-clear-street-group-inc/) | $4.4K | 34,082 | 0.0% | 4 |
| [CITIGROUP INC](https://holderbook.com/funds/831001-citigroup-inc/) | $3.9K | 0 | 0.0% | 11 |
| [TORONTO DOMINION BANK](https://holderbook.com/funds/947263-toronto-dominion-bank/) | $2.8K | 21,635 | 0.0% | 5 |
| [SkyView Investment Advisors, LLC](https://holderbook.com/funds/1848237-skyview-investment-advisors-llc/) | $8 | 62,500 | 0.0% | 11 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 8 | $245.1K |
| Q1 2026 | 7 | $24.2K |
| Q4 2025 | 8 | $19.5K |
| Q3 2025 | 12 | $28.4K |
| Q2 2025 | 12 | $27.4K |
| Q1 2025 | 11 | $88.4K |
| Q4 2024 | 12 | $80.9K |
| Q3 2024 | 14 | $77.5K |
| Q2 2024 | 16 | $57.2K |
| Q1 2024 | 15 | $67.3K |
| Q4 2023 | 15 | $34.2K |
| Q3 2023 | 1 | $1.7K |